Medicare Enrolled

Dr. Kenneth Liss, DO

Nephrology Specialist/Technologist · Eatontown, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
6 INDUSTRIAL WAY W, Eatontown, NJ 07724
7324601200
In practice since 2006 (19 years)
NPI: 1033125315 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liss? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liss

Dr. Kenneth Liss is a nephrology specialist/technologist specialist in Eatontown, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Liss performed 1,943 Medicare services across 1,029 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liss received a total of $92,655 from 47 pharmaceutical and/or device companies across 707 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology specialist/technologist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,943 Medicare services $92,655 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,943
Medicare services
1.0× state median for nephrology specialist/technologist
1,029
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
644 $97 $175
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
606 $67 $106
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
155 $298 $406
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
132 $143 $305
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
101 $60 $96
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
67 $101 $132
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
66 $136 $201
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
45 $3 $10
New patient office visit, complex (60-74 min) 34 $165 $260
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
31 $8 $10
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
20 $250 $375
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
17 $19 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $64 $125
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $110 $165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$92,655
Total received (2018-2024)
Avg $13,236/year across 7 years
1.0× state median for specialty
47
Companies
707
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84,550 (91.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,105 (8.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,692
2023
$9,956
2022
$5,337
2021
$11,107
2020
$10,685
2019
$21,969
2018
$20,908

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$9,896
CSL Behring
$1,817
OPKO Pharmaceuticals, LLC
$166
Bayer Healthcare Pharmaceuticals Inc.
$162
Amgen Inc.
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Ardelyx, Inc.
$84
Aurinia Pharma U.S., Inc.
$68
Novartis Pharmaceuticals Corporation
$49
Mallinckrodt Hospital Products Inc.
$45
Fresenius USA Marketing, Inc.
$33
Otsuka America Pharmaceutical, Inc.
$31
Travere Therapeutics, Inc.
$30
GlaxoSmithKline, LLC.
$28
CALLIDITAS THERAPEUTICS US INC.
$16
Novo Nordisk Inc
$15
Vifor Pharma, Inc.
$14
Top 3 companies account for 93.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$37,457
Otsuka America Pharmaceutical, Inc.
$35,429
Amgen Inc.
$12,058
CSL Behring
$1,817
ARBOR PHARMACEUTICALS, INC.
$751
OPKO Pharmaceuticals, LLC
$623
Aurinia Pharma U.S., Inc.
$575
Fresenius USA Marketing, Inc.
$518
GlaxoSmithKline, LLC.
$313
Horizon Therapeutics plc
$311
Vifor Pharma, Inc.
$311
Mallinckrodt Hospital Products Inc.
$305
Relypsa, Inc.
$266
Bayer Healthcare Pharmaceuticals Inc.
$215
Bayer HealthCare Pharmaceuticals Inc.
$194
Daiichi Sankyo Inc.
$175
Novo Nordisk Inc
$153
AKEBIA THERAPEUTICS INC
$134
Lundbeck LLC
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Ardelyx, Inc.
$98
Allergan Inc.
$82
Travere Therapeutics, Inc.
$57
Amarin Pharma Inc.
$56
Novartis Pharmaceuticals Corporation
$49
CALLIDITAS THERAPEUTICS US INC.
$48
Keryx Biopharmaceuticals, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$38
ANI Pharmaceuticals, Inc.
$32
Otsuka Pharmaceutical Development & Commercialization, Inc.
$30
Mallinckrodt LLC
$28
Strongbridge US INC.
$26
Cumberland Pharmaceuticals, Inc.
$24
Calliditas Therapeutics US Inc.
$19
Genentech USA, Inc.
$18
Exeltis, USA Inc.
$16
Ultragenyx Pharmaceutical Inc.
$15
West-Ward Pharmaceuticals
$15
Azurity Pharmaceuticals, Inc.
$15
FRESENIUS USA MANUFACTURING, INC.
$15
Retrophin, Inc.
$15
BAXTER HEALTHCARE
$14
Xeris Pharmaceuticals, Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
Shire North American Group Inc
$14
Arbor Pharmaceuticals, Inc.
$12
CHIESI USA, INC.
$12
Top 3 companies account for 91.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · BRILINTA · BYSTOLIC · Bidil · CLEVIPREX 25MG/50ML · Cryvista · EVUSHELD · Edarbi · Edarbyclor · Evekeo ODT · FARXIGA · Fabhalta · GATTEX · GVOKE PFS · Horizant · IBSRELA · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · Korsuva · LOKELMA · LUPKYNIS · Mitigare · NORTHERA · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Renal - Non Product Related · Repatha · Rituxan · Rybelsus · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Vaprisol Dextrose in Plastic Container · Vascepa · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology specialist/technologist and does not inherently indicate bias, but patients may wish to be aware.

Looking for a nephrology specialist/technologist specialist in Eatontown?
Compare nephrology specialist/technologists in the Eatontown area by procedure volume, costs, and industry payment transparency.
Browse nephrology specialist/technologists nearby

Geographic Context

Nephrology specialist/technologists within 10 mi
2
Per 100K population
0.3
County median income
$122,727
Nearest hospital
RIVERVIEW MEDICAL CENTER
4.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liss is a clinical cardiology specialist, with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liss experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Liss performed 644 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liss receive payments from pharmaceutical companies?
Yes. Dr. Liss received a total of $92,655 from 47 companies across 707 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liss's costs compare to other nephrology specialist/technologists in Eatontown?
Dr. Liss's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →